747 52nd Street, Oakland, CA, 94609 · (510) 428-3000
Beds
163
FY 2025
Star rating
Not rated
Overall rating
Net patient revenue
$711.5M
FY 2025
Net income
$212.2M
Patient care margin 3.5%
Discharges
7,496
Occupancy 65.9%
Clinicians
14
Medicare clinicians who work here
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $711.5M | $686.3M | 3.5% | $212.2M | 7,496 | - | 0.0% | 46.5% |
Medicare clinicians who list this hospital, by specialty
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5182 Level 2 Vascular Procedures | - | - | - | $1,204.32 |
| APC 5503 Level 3 Extraocular, Repair, and Plastic Eye Procedures | - | - | - | $1,780.31 |
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
| 2024 | $820.6M | $803.6M | 2.1% | $96.8M | 7,386 | - | 0.0% | 44.1% |
| 2023 | $687.9M | $736.4M | -7.0% | $7.5M | 7,574 | - | 0.2% | 45.1% |
| 2022 | $641.4M | $674.7M | -5.2% | $28.9M | 7,373 | - | 0.1% | 45.0% |
| 2021 | $559.5M | $619.1M | -10.6% | $18.3M | 6,714 | - | 0.1% | 42.5% |
| 2020 | $570.5M | $669.2M | -17.3% | -$13.7M | 7,894 | - | 0.1% | 50.7% |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 10 | $173K |
| Genetix Biotherapeutics Inc | 6 | $36K |
| Sanofi-Aventis U.S. LLC SNY | 1 | $2,000 |
| New York Blood Center, Inc. | 1 | $1,300 |
| Haemonetics Corporation HAE | 1 | $867 |
| BioMarin Pharmaceutical Inc. BMRN | 12 | $840 |
| Life Technologies Corporation | 1 | $98.49 |
| Teleflex LLC TFX | 1 | $66 |
| KARL STORZ Endoscopy-America | 1 | $32.5 |
| Stryker Corporation SYK | 1 | $17.95 |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
UCSF Benioff Children's Hospital Oakland is a nonprofit children's hospital in Oakland, CA with 163 beds, part of University of California.
UCSF Benioff Children's Hospital Oakland in Oakland, CA has 163 beds (fiscal year 2025 cost report); 190 beds are certified for Medicare. It discharged 7,496 inpatients that year, with 65.9% of its beds in use on average.
In fiscal year 2025 (ending 2025-06-30), UCSF Benioff Children's Hospital Oakland reported net patient revenue of $711.5M and operating expenses of $686.3M, a margin on patient care of 3.5%. After other income and expenses its net income was $212.2M (23.6% of revenue), so it made a profit that year.
UCSF Benioff Children's Hospital Oakland is part of University of California, a health system with 2 hospitals based in Oakland, CA. It is a nonprofit hospital.
UCSF Benioff Children's Hospital Oakland has no overall star rating, usually because it reports too few quality measures (for example small, specialty or federal hospitals).
Yes, UCSF Benioff Children's Hospital Oakland provides emergency services.
14 Medicare clinicians list UCSF Benioff Children's Hospital Oakland as a hospital they work at, most often in Pediatric Medicine, Hematology/Oncology, Nurse Practitioner.
In 2025, companies reported $214K in payments to UCSF Benioff Children's Hospital Oakland as a teaching hospital ($6,382 general and $207K for research) from 10 companies.